383
Participants
Start Date
March 31, 2015
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Embol-X Embolic Protection Device
per the manufacturer's instructions for use (IFU).
CardioGard Cannula
CardioGard Cannula, per the manufacturer's instructions for use (IFU).
Columbia University Medical Center, New York
Montefiore Einstein Heart Center, The Bronx
University of Pennsylvania, Philadelphia
NIH Heart Center at Suburban Hospital, Bethesda
University of Maryland, Baltimore
University of Virginia, Charlottesville
Duke University, Durham
Mission Hospital, Asheville
Emory University, Atlanta
Ohio State University, Columbus
Cleveland Clinic Foundation, Cleveland
Baylor Research Institute, Plano
University of Southern California, Los Angeles
Dartmouth-Hitchcock Medical Center, Lebanon
University of Alberta Hospital, Edmonton
Toronto General Hospital, Toronto
Montreal Heart Institute, Montreal
Institut Universitaire de Cardiologie de Quebec (Hopital Laval), Québec
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Icahn School of Medicine at Mount Sinai
OTHER